224 related articles for article (PubMed ID: 15519010)
1. Cost-effectiveness of distal embolic protection for patients undergoing percutaneous intervention of saphenous vein bypass grafts: results from the SAFER trial.
Cohen DJ; Murphy SA; Baim DS; Lavelle TA; Berezin RH; Cutlip DE; Ho KK; Kuntz RE;
J Am Coll Cardiol; 2004 Nov; 44(9):1801-8. PubMed ID: 15519010
[TBL] [Abstract][Full Text] [Related]
2. Clinical and economic outcomes of embolic complications and strategies for distal embolic protection during percutaneous coronary intervention in saphenous vein grafts.
Senter SR; Nathan S; Gupta A; Klein LW
J Invasive Cardiol; 2006 Feb; 18(2):49-53. PubMed ID: 16446515
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of sirolimus-eluting stents for treatment of complex coronary stenoses: results from the Sirolimus-Eluting Balloon Expandable Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions (SIRIUS) trial.
Cohen DJ; Bakhai A; Shi C; Githiora L; Lavelle T; Berezin RH; Leon MB; Moses JW; Carrozza JP; Zidar JP; Kuntz RE;
Circulation; 2004 Aug; 110(5):508-14. PubMed ID: 15262844
[TBL] [Abstract][Full Text] [Related]
4. Cost effectiveness of paclitaxel-eluting stents for patients undergoing percutaneous coronary revascularization: results from the TAXUS-IV Trial.
Bakhai A; Stone GW; Mahoney E; Lavelle TA; Shi C; Berezin RH; Lahue BJ; Clark MA; Lacey MJ; Russell ME; Ellis SG; Hermiller JB; Cox DA; Cohen DJ;
J Am Coll Cardiol; 2006 Jul; 48(2):253-61. PubMed ID: 16843171
[TBL] [Abstract][Full Text] [Related]
5. Poor long-term patient and graft survival after primary percutaneous coronary intervention for acute myocardial infarction due to saphenous vein graft occlusion.
Brodie BR; VerSteeg DS; Brodie MM; Hansen C; Richter SJ; Stuckey TD; Gupta N; Pulsipher M; Downey W
Catheter Cardiovasc Interv; 2005 Aug; 65(4):504-9. PubMed ID: 15988742
[TBL] [Abstract][Full Text] [Related]
6. The PROXIMAL trial: proximal protection during saphenous vein graft intervention using the Proxis Embolic Protection System: a randomized, prospective, multicenter clinical trial.
Mauri L; Cox D; Hermiller J; Massaro J; Wahr J; Tay SW; Jonas M; Popma JJ; Pavliska J; Wahr D; Rogers C
J Am Coll Cardiol; 2007 Oct; 50(15):1442-9. PubMed ID: 17919563
[TBL] [Abstract][Full Text] [Related]
7. Randomized comparison of distal protection with a filter-based catheter and a balloon occlusion and aspiration system during percutaneous intervention of diseased saphenous vein aorto-coronary bypass grafts.
Stone GW; Rogers C; Hermiller J; Feldman R; Hall P; Haber R; Masud A; Cambier P; Caputo RP; Turco M; Kovach R; Brodie B; Herrmann HC; Kuntz RE; Popma JJ; Ramee S; Cox DA;
Circulation; 2003 Aug; 108(5):548-53. PubMed ID: 12874191
[TBL] [Abstract][Full Text] [Related]
8. Failure of the Symbiot PTFE-covered stent to reduce distal embolization during percutaneous coronary intervention in saphenous vein grafts.
Blackman DJ; Choudhury RP; Banning AP; Channon KM
J Invasive Cardiol; 2005 Nov; 17(11):609-12. PubMed ID: 16264208
[TBL] [Abstract][Full Text] [Related]
9. Six-month outcomes after percutaneous intervention for lesions in aortocoronary saphenous vein grafts using distal protection devices: results from the FIRE trial.
Halkin A; Masud AZ; Rogers C; Hermiller J; Feldman R; Hall P; Haber RH; Cambier PA; Caputo RP; Turco M; Kovach R; Brodie B; Herrmann HC; Kuntz RE; Popma JJ; Ramee S; Cox DA; Mehran R; Stone GW
Am Heart J; 2006 Apr; 151(4):915.e1-7. PubMed ID: 16569562
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous intervention of acutely occluded saphenous vein grafts: contemporary techniques and outcomes.
Abdel-Karim AR; Banerjee S; Brilakis ES
J Invasive Cardiol; 2010 Jun; 22(6):253-7. PubMed ID: 20516502
[TBL] [Abstract][Full Text] [Related]
11. Initial clinical experience with distal protection using the FilterWire in patients undergoing coronary artery and saphenous vein graft percutaneous intervention.
Popma JJ; Cox N; Hauptmann KE; Reifart N; Virmani R; Emira K; Murphy S; Gibson CM; Grube E
Catheter Cardiovasc Interv; 2002 Oct; 57(2):125-34. PubMed ID: 12357506
[TBL] [Abstract][Full Text] [Related]
12. Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts.
Baim DS; Wahr D; George B; Leon MB; Greenberg J; Cutlip DE; Kaya U; Popma JJ; Ho KK; Kuntz RE;
Circulation; 2002 Mar; 105(11):1285-90. PubMed ID: 11901037
[TBL] [Abstract][Full Text] [Related]
13. Percutaneous saphenous vein graft interventions with and without distal filter wire protection.
Hofmann M; Störger H; Schwarz F; Schwarz CE; Reinemer H; Ruef J; Schöpf J; Haase J
J Interv Cardiol; 2005 Dec; 18(6):475-9. PubMed ID: 16336428
[TBL] [Abstract][Full Text] [Related]
14. Limitations of using a GuardWire temporary occlusion and aspiration system in patients with acute myocardial infarction: multicenter investigation of coronary artery protection with a distal occlusion device in acute myocardial infarction (MICADO).
Matsuo A; Inoue N; Suzuki K; Nakamura R; Fujita H; Miki S; Yokoi Y
J Invasive Cardiol; 2007 Mar; 19(3):132-8. PubMed ID: 17341781
[TBL] [Abstract][Full Text] [Related]
15. Percutaneous coronary intervention of or through saphenous vein grafts or internal mammary arteries: the impact of stents, adjunctive pharmacology, and multicomponent distal protection.
Morrison DA; Thai H; Goldman S; Felix E; Hernandez J
Catheter Cardiovasc Interv; 2006 Apr; 67(4):571-9. PubMed ID: 16547927
[TBL] [Abstract][Full Text] [Related]
16. Impact of diabetes on five-year outcomes after vein graft interventions performed prior to the drug-eluting stent era.
Ashfaq S; Ghazzal Z; Douglas JS; Morris DC; Veledar E; Weintraub WS
J Invasive Cardiol; 2006 Mar; 18(3):100-5. PubMed ID: 16598106
[TBL] [Abstract][Full Text] [Related]
17. Utilization of distal embolic protection in saphenous vein graft interventions (an analysis of 19,546 patients in the American College of Cardiology-National Cardiovascular Data Registry).
Mehta SK; Frutkin AD; Milford-Beland S; Klein LW; Shaw RE; Weintraub WS; Krone RJ; Anderson HV; Kutcher MA; Marso SP;
Am J Cardiol; 2007 Oct; 100(7):1114-8. PubMed ID: 17884373
[TBL] [Abstract][Full Text] [Related]
18. Platelet glycoprotein IIb/IIIa receptor inhibition as adjunctive treatment during saphenous vein graft stenting: differential effects after randomization to occlusion or filter-based embolic protection.
Jonas M; Stone GW; Mehran R; Hermiller J; Feldman R; Herrmann HC; Cox DA; Kuntz RE; Popma JJ; Rogers C;
Eur Heart J; 2006 Apr; 27(8):920-8. PubMed ID: 16415300
[TBL] [Abstract][Full Text] [Related]
19. Distal embolic protection for SVG interventions: can we afford not to use it?
Shaia N; Heuser RR
J Interv Cardiol; 2005 Dec; 18(6):481-4. PubMed ID: 16336429
[TBL] [Abstract][Full Text] [Related]
20. A novel filter-based distal embolic protection device for percutaneous intervention of saphenous vein graft lesions: results of the AMEthyst randomized controlled trial.
Kereiakes DJ; Turco MA; Breall J; Farhat NZ; Feldman RL; McLaurin B; Popma JJ; Mauri L; Zimetbaum P; Massaro J; Cutlip DE;
JACC Cardiovasc Interv; 2008 Jun; 1(3):248-57. PubMed ID: 19463308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
